Together, the data suggests a close preclinical/prodromal relationship between non-plaque Aβ and tau in cases of low AD neuropathic change, which is at least partially due to the accumulation of intracellular Aβ and its potential influence on tau phosphorylation. The gene discussed is MAPT; the disease is Alzheimer disease.